TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue -, Pages 15395
Publisher
Springer Nature
Online
2017-05-22
DOI
10.1038/ncomms15395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum levels of TWEAK in patients with psoriasis vulgaris
- (2016) Özlem Bilgiç et al. CYTOKINE
- Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis
- (2016) Britta C. Martel et al. EXPERIMENTAL DERMATOLOGY
- The adaptive immune system in atopic dermatitis and implications on therapy
- (2016) Lennart M. Roesner et al. Expert Review of Clinical Immunology
- Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial
- (2015) K. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation
- (2015) Hong Cheng et al. EXPERIMENTAL DERMATOLOGY
- Evolution pathways of IgE responses to grass and mite allergens throughout childhood
- (2015) Adnan Custovic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The immunogenetics of Psoriasis: A comprehensive review
- (2015) Jamie L. Harden et al. JOURNAL OF AUTOIMMUNITY
- The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis
- (2015) Rana Herro et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus
- (2015) Jessica L. Doerner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
- (2015) Christopher E M Griffiths et al. LANCET
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1
- (2015) Nima Etemadi et al. eLife
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis
- (2014) Ellen Witte et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption
- (2014) K.B. Gordon et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis
- (2014) Bogusław Nedoszytko et al. Postepy Dermatologii i Alergologii
- TWEAK/Fn14 axis: The current paradigm of tissue injury-inducible function in the midst of complexities
- (2014) Linda C. Burkly SEMINARS IN IMMUNOLOGY
- Critical Role for Mast Cell Stat5 Activity in Skin Inflammation
- (2014) Tomoaki Ando et al. Cell Reports
- Thymic Stromal Lymphopoietin Is Up-Regulated in the Skin of Patients With Systemic Sclerosis and Induces Profibrotic Genes and Intracellular Signaling That Overlap With Those Induced by Interleukin-13 and Transforming Growth Factor β
- (2013) Romy B. Christmann et al. ARTHRITIS AND RHEUMATISM
- Mast Cells Are Required for Full Expression of Allergen/SEB-Induced Skin Inflammation
- (2013) Tomoaki Ando et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Clinical targeting of the TNF and TNFR superfamilies
- (2013) Michael Croft et al. NATURE REVIEWS DRUG DISCOVERY
- Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice
- (2013) Jun Sun et al. PLoS One
- TSLP Elicits IL-33-Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation
- (2013) B. S. Kim et al. Science Translational Medicine
- Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis
- (2012) Y. Sano et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- TSLP: From allergy to vaccine adjuvant
- (2012) Vassili Soumelis EUROPEAN JOURNAL OF IMMUNOLOGY
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
- (2012) Julia K. Gittler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
- (2012) David A. Martin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
- (2011) Linda C. Burkly et al. IMMUNOLOGICAL REVIEWS
- TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis
- (2011) Maya Zimmermann et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Expression of BAFF, APRIL and TWEAK Is Altered in Eczema Skin but Not in the Circulation of Atopic and Seborrheic Eczema Patients
- (2011) Yunying Chen et al. PLoS One
- TNF superfamily in inflammatory disease: translating basic insights
- (2011) Michael Croft et al. TRENDS IN IMMUNOLOGY
- The role of thymic stromal lymphopoietin (TSLP) in allergic disorders
- (2010) Steven F Ziegler CURRENT OPINION IN IMMUNOLOGY
- Sensing the outside world: TSLP regulates barrier immunity
- (2010) Steven F Ziegler et al. NATURE IMMUNOLOGY
- Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells
- (2010) S. Stutte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenesis of atopic dermatitis: New developments
- (2009) Thomas Bieber et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Proinflammatory Effect of TWEAK/Fn14 Interaction in Human Retinal Pigment Epithelial Cells
- (2009) Nobuyuki Ebihara et al. CURRENT EYE RESEARCH
- TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells
- (2009) Hua-Xin Gao et al. CYTOKINE
- CCR6 is required for IL-23–induced psoriasis-like inflammation in mice
- (2009) Michael N. Hedrick et al. JOURNAL OF CLINICAL INVESTIGATION
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
- (2009) L. van der Fits et al. JOURNAL OF IMMUNOLOGY
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association analysis of IL20RA and IL20RB genes in psoriasis
- (2008) K Kingo et al. GENES AND IMMUNITY
- Chemokine receptor antagonists: overcoming developmental hurdles
- (2008) Richard Horuk NATURE REVIEWS DRUG DISCOVERY
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started